1. Home
  2. DORM vs LEGN Comparison

DORM vs LEGN Comparison

Compare DORM & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dorman Products Inc.

DORM

Dorman Products Inc.

SELL

Current Price

$123.28

Market Cap

3.8B

ML Signal

SELL

LEGN

Legend Biotech Corporation

SELL

Current Price

$18.60

Market Cap

3.6B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
DORM
LEGN
Founded
1978
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.8B
3.6B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
DORM
LEGN
Price
$123.28
$18.60
Analyst Decision
Buy
Buy
Analyst Count
8
13
Target Price
★ $161.63
$45.62
AVG Volume (30 Days)
216.5K
★ 2.0M
Earning Date
10-26-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 8.14
N/A
EPS
★ 4.35
N/A
Revenue
★ $2,130,319,000.00
N/A
Revenue This Year
$3.68
$39.73
Revenue Next Year
$4.98
$23.42
P/E Ratio
$28.36
★ N/A
Revenue Growth
★ 6.03
N/A
52 Week Low
$98.45
$16.24
52 Week High
$164.00
$37.50

Technical Indicators

Market Signals
Indicator
DORM
LEGN
Relative Strength Index (RSI) 47.40 48.51
Support Level $119.56 $16.98
Resistance Level $127.20 $19.92
Average True Range (ATR) 3.34 0.87
MACD 0.35 0.13
Stochastic Oscillator 55.57 53.18

Price Performance

Historical Comparison
DORM
LEGN

About DORM Dorman Products Inc.

Dorman Products Inc is a supplier of original equipment parts for automobiles. It offers automotive and heavy-duty replacement parts, automotive hardware, brake parts, and fasteners for the automotive and heavy-duty aftermarket. The products are sold under the Dorman brand and its sub-brands OE Solutions, Help!, Conduct-Tite, Super ATV, etc., through aftermarket retailers, warehouse distributors, specialty markets, and salvage yards. The company operates through three business segments, which include Light Duty, Heavy Duty, and Specialty Vehicle. A majority of its revenue is generated from the Light Duty segment, which designs and markets replacement parts and fasteners mainly for passenger cars and light trucks. Geographically, it derives key revenue from the United States.

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Share on Social Networks: